<DOC>
	<DOCNO>NCT01428440</DOCNO>
	<brief_summary>Apoptosis program cell death disrupt cancer cell allow live longer . A number anti-cancer agent induce apoptosis mechanism drug action get rid cancer . A biomarker would allow apoptosis tumour image directly would provide powerful new tool oncology drug development potentially contribute improve patient care . In study , propose evaluate [ 18F ] ML10-PET image tumour apoptosis patient receive standard chemotherapy treatment cancer .</brief_summary>
	<brief_title>PET Study Study Tumour Apoptosis</brief_title>
	<detailed_description />
	<criteria>Male female patient &gt; 18 year age screen histological cytological diagnosis nonHodgkin 's lymphoma , small cell lung cancer , breast ovarian cancer work clinically ( see ) due receive standard chemotherapy treatment , enrol prior initiation chemotherapy . A female subject eligible participate nonchildbearing potential childbearing potential agrees use one contraception method list . Male subject eligible participate also agree use one contraception method list . Tumour consider investigator able image use PET ( 2cm size ) Able lie comfortably back 65 minute time . Capable give write informed consent , willing able comply requirement restriction list consent form . Patients deemed fit receive chemotherapy treatment oncologist . WHO performance status 0 , 1 2 . Any medical psychiatric diagnosis symptoms social situation view investigator would limit compliance study requirement . Pregnant breast feeding female . Received anticancer therapy ( radiotherapy , chemotherapy , immunotherapy ) investigational agent , include investigational anticancer agent within 28 day prior first [ 18F ] ML10PET scan . History sensitivity heparin heparininduced thrombocytopenia . Inability comply contraceptive guideline study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>